News

News about advances made possible through IPIRA's work, such as innovations commercialized, campus partnerships with industry, and companies born out of licensing UC Berkeley intellectual property rights.

All News

January 14, 2026

Integrated DNA Technologies Expands Synthetic Biology Portfolio with Ansa Biotechnologies’ Clonal DNA and XL Clonal DNA Products

link

November 12, 2025

Ansa Biotechnologies Sets New Standard in Long, Complex DNA

link

October 22, 2025

Ansa Biotechnologies Redefines What’s Possible in DNA Synthesis with 50 kb Sequence-Perfect Clonal Product

link

October 1, 2025

Ansa Biotechnologies Secures $54.4 Million in Series B Financing to Redefine How Scientists Access Synthetic DNA with Industry’s First Guaranteed On-Time Service

link

June 25, 2025

DOE Recognizes Synthetic Biology Pioneer Jay Keasling with 2025 OTC/NAI Innovator of the Year Award

link

January 27, 2025

For Gene Therapy Development, High-Quality Synthetic DNA Matters

link

November 12, 2024

Ansa Biotechnologies Sets New Standard in Long, Complex DNA

link

May 6, 2024

Ansa Biotechnologies Expands Successful Early Access Program for Complex DNA Synthesis

https://www.businesswire.com/news/home/20240506859635/en/Ansa-Biotechnol...

April 11, 2022

Ansa Biotechnologies Closes $68M Series A Financing

Link

September 17, 2020

Ansa Biotechnologies Wants to Usher in a New Era of DNA manufacturing

Link

February 24, 2020

How to Build a Genome

Link

December 18, 2018

Four Synthetic Biology Startups to Watch in 2019

Link